AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABVC BIOPHARMA, INC. Director's Dealing 2021

Nov 15, 2021

34380_dirs_2021-11-15_95254a16-5fb7-4403-9816-8c64c0c5cc69.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ABVC BIOPHARMA, INC. (ABVC)
CIK: 0001173313
Period of Report: 2021-08-02

Reporting Person: Miao Shin-Yu (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	67378	Indirect

Footnotes

F1: Dr. Shin-Yu Miao holds 1,705 shares of the Company's common stock through her ownership in BioFirst, 7 shares of the Company's common stock through her ownership in Rgene, and the rest of 65,666 through direct ownership.